BPES is delighted to announce a strategic partnership with SEED Biosciences, a Swiss biotech innovator specialising in automated single-cell dispensing solutions. Through this collaboration, BPES will bring SEED Biosciences’ DispenCell-S4system to customers in the UK, enhancing laboratories’ capabilities in single-cell workflows for research and bioprocess development.
As single-cell applications become central to biotech and biopharmaceutical innovation – from cell line development to gene editing and monoclonal antibody discovery – demand is rising for technologies that improve consistency, reduce manual handling, and support regulated workflows. SEED Biosciences’ technology meets these needs with a focus on automation, efficiency, and compatibility with high-quality workflows.
Why This Partnership Matters
Together, BPES and SEED Biosciences enable laboratories to reduce variability and streamline workflows requiring controlled single-cell isolation. BPES’ expertise in bioprocess technology integration, complementary product portfolio and local support enhances SEED’s precision dispensing technology – helping labs adopt advanced solutions with confidence.
